A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaJie Wang,Adam S. Asch,Nada Hamad,Andrew Weickhardt,Monika Tomaszewska-Kiecana,Monika Dlugosz-Danecka,Halyna Pylypenko,Shakeela Bahadur,Susanna Ulahannan,Janine Koucheki,Jichao Sun,Hua Li,Francine Chen,Xiaoyu Zhang,John Muth,Patrick Kaminker,Paul Moore,Bradley James SumrowBLOOD（2020）引用 16|浏览35AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
